Skip to main content

New Allergy Section

We are delighted to announce that Asthma Research and Practice has launched a new allergy section that is now open to submissions! The section is edited by Dr Olympia Tsilochristou MD PhD, Consultant Allergist and considers all aspects of allergy with a particular focus on links between asthma and allergic rhinitis, drug hypersensitivity reactions, and food allergy as well as on allergen immunotherapy and biologicals for asthma/allergic rhinitis. If you would like more information on the section’s aims and scopes or on the suitability of your manuscript for the journal, please do reach out using the Contact button at the bottom of the page.

Featured article: Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma

Lombardi et al 2022Small airway dysfunction (SAD) in asthma is characterized by the inflammation and narrowing of airways with less of 2 mm in diameter between generations 8 and 23 of the bronchial tree. It is now widely accepted that small airways are involved in the pathogenesis of asthma and are a major determinant of airflow obstruction in this disease. Biologic agents are now available for the treatment of different severe asthma phenotypes and endotypes. However, the effect of these therapies on SAD remains poorly characterized. In this mini-review article, we address the latest evidence on the effect of biological therapies on SAD in patients with severe asthma.

Read the article 


Aims and scope

Asthma Research and Practice publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research.

Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.

Annual Journal Metrics

  • Speed
    23 days to first decision for all manuscripts (Median)
    30 days to first decision for reviewed manuscripts only (Median)

    120,875 Downloads (2022)
    213 Altmetric mentions (2021)